<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=1080">
<title>Intracranial Pressure Management ‚Äî CCM Protocol Card</title>
<style>
@import url('https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800;900&family=JetBrains+Mono:wght@400;600&display=swap');
*{box-sizing:border-box;margin:0;padding:0}
body{font-family:'Inter','Segoe UI',system-ui,sans-serif;background:#111827;display:flex;justify-content:center;padding:0}
.card{width:1080px;height:1350px;background:#0d1b2a;display:flex;flex-direction:column;overflow:hidden;position:relative}

.hdr{background:linear-gradient(135deg,#0a0520 0%,#1a0a40 40%,#112233 100%);padding:26px 42px 20px;border-bottom:3px solid #12b5b5;flex-shrink:0;position:relative;overflow:hidden}
.hdr::after{content:'ICP';position:absolute;right:10px;top:-10px;font-size:130px;font-weight:900;color:rgba(255,255,255,0.04);letter-spacing:-4px;line-height:1}
.logo-row{display:flex;align-items:center;gap:8px;margin-bottom:5px}
.logo{font-size:11px;font-weight:700;letter-spacing:3px;color:#12b5b5;text-transform:uppercase}
.cat{font-size:11px;color:#7aaeae;letter-spacing:2px;text-transform:uppercase}
.sep-dot{color:#12b5b5;opacity:.5}
.title{font-size:38px;font-weight:900;color:#fff;line-height:1.1;margin-top:4px}
.subtitle{font-size:13px;color:#b0d8d8;margin-top:4px}

.body{flex:1;padding:14px 42px 10px;display:flex;flex-direction:column;gap:10px;overflow:hidden}
.box{background:#112233;border-radius:10px;padding:13px 16px;border-left:4px solid #12b5b5}
.box.amber{border-left-color:#f5a623}
.box.red{border-left-color:#e74c3c}
.box.green{border-left-color:#27ae60}
.box.blue{border-left-color:#3498db}
.box.purple{border-left-color:#9b59b6}
.box.orange{border-left-color:#e67e22}
.sec-lbl{font-size:10px;font-weight:700;letter-spacing:2px;text-transform:uppercase;color:#12b5b5;margin-bottom:8px}
.box.amber .sec-lbl{color:#f5a623}
.box.red .sec-lbl{color:#e74c3c}
.box.green .sec-lbl{color:#27ae60}
.box.blue .sec-lbl{color:#3498db}
.box.purple .sec-lbl{color:#9b59b6}
.box.orange .sec-lbl{color:#e67e22}

.two-col{display:grid;grid-template-columns:1fr 1fr;gap:10px}
.three-col{display:grid;grid-template-columns:1fr 1fr 1fr;gap:9px}
.mini-box{background:#1a2e44;border-radius:8px;padding:10px 12px}
.mini-title{font-size:10.5px;font-weight:700;color:#7aaeae;text-transform:uppercase;letter-spacing:1.5px;margin-bottom:6px}
.item{font-size:12px;color:#d0e8e8;padding:2px 0 2px 14px;position:relative;line-height:1.35}
.item::before{content:'‚ñ∏';position:absolute;left:0;color:#12b5b5;font-size:9px;top:4px}
.val{font-family:'JetBrains Mono','Courier New',monospace;color:#f5a623;font-weight:600;font-size:11.5px}

/* ICP target bands */
.target-bands{display:flex;gap:8px;margin-top:4px}
.tb-cell{flex:1;border-radius:7px;padding:9px 12px;text-align:center}
.tb-normal{background:rgba(39,174,96,.12);border:1px solid rgba(39,174,96,.35)}
.tb-elevated{background:rgba(245,166,35,.12);border:1px solid rgba(245,166,35,.35)}
.tb-critical{background:rgba(231,76,60,.12);border:1px solid rgba(231,76,60,.35)}
.tb-val{font-family:'JetBrains Mono',monospace;font-size:18px;font-weight:800;line-height:1}
.tb-val-green{color:#27ae60}
.tb-val-amber{color:#f5a623}
.tb-val-red{color:#e74c3c}
.tb-label{font-size:10.5px;color:#d0e8e8;margin-top:4px;font-weight:600}

/* Monroe-Kellie + CPP inline */
.doctrine-row{display:grid;grid-template-columns:1.2fr 1fr;gap:10px;margin-top:8px}
.doctrine-box{background:#1a2e44;border-radius:8px;padding:9px 12px}
.dt-label{font-size:10px;font-weight:700;color:#7aaeae;text-transform:uppercase;letter-spacing:1.5px;margin-bottom:5px}
.formula-inline{font-family:'JetBrains Mono',monospace;font-size:14px;font-weight:700;color:#12b5b5;margin-bottom:4px}

/* Stepwise protocol */
.step-grid{display:grid;grid-template-columns:repeat(4,1fr);gap:8px}
.step-cell{background:#1a2e44;border-radius:8px;padding:10px 10px}
.step-tier{font-size:10px;font-weight:700;color:#7aaeae;text-transform:uppercase;letter-spacing:1.2px;margin-bottom:3px}
.step-title{font-size:12.5px;font-weight:800;color:#fff;margin-bottom:4px}
.step-detail{font-size:10.5px;color:#b0d8d8;line-height:1.4}
.tier-1{border-top:3px solid #27ae60}
.tier-2{border-top:3px solid #f5a623}
.tier-3{border-top:3px solid #e67e22}
.tier-4{border-top:3px solid #e74c3c}

/* Cushing's triad alert */
.cushing-alert{background:rgba(231,76,60,.08);border:2px solid rgba(231,76,60,.5);border-radius:10px;padding:11px 16px;display:flex;align-items:center;gap:16px}
.cushing-icon{font-size:32px;flex-shrink:0}
.cushing-body{flex:1}
.cushing-title{font-size:14px;font-weight:800;color:#e74c3c;margin-bottom:4px}
.cushing-triad{display:flex;gap:10px;flex-wrap:wrap}
.ct-item{background:rgba(231,76,60,.15);border-radius:5px;padding:4px 10px;font-size:12px;font-weight:700;color:#f0b8b0}
.cushing-action{font-size:11.5px;color:#f0b8b0;margin-top:5px;font-weight:500}

/* Osmotherapy compare */
.osmo-grid{display:grid;grid-template-columns:1fr 1fr;gap:9px}
.osmo-cell{border-radius:8px;padding:10px 12px}
.oc-mannitol{background:#0a1520;border:1px solid rgba(52,152,219,.25);border-top:3px solid #3498db}
.oc-hts{background:#150a20;border:1px solid rgba(155,89,182,.25);border-top:3px solid #9b59b6}
.oc-drug{font-size:13px;font-weight:800;margin-bottom:4px}
.oc-drug-blue{color:#3498db}
.oc-drug-purple{color:#9b59b6}

/* Warnings */
.warn-row{display:flex;gap:8px;align-items:flex-start;padding:3px 0}
.warn-icon{color:#e74c3c;font-size:11px;flex-shrink:0;margin-top:2px}
.warn-text{font-size:11.5px;color:#f0b8b0;line-height:1.35}

.ftr{background:#112233;border-top:1px solid rgba(18,181,181,.25);padding:12px 42px;display:flex;align-items:center;justify-content:space-between;flex-shrink:0;flex-wrap:wrap;gap:12px}
.ftr-left{font-size:11px;color:#b0d8d8;font-weight:500;line-height:1.6}
.ftr-note{font-size:9px;color:#7aaeae;text-align:right;line-height:1.4}

@media (max-width:1100px){.card{width:100%;height:auto;min-height:1350px}}
@media (max-width:768px){
.hdr{padding:18px 24px 14px}
.title{font-size:30px}
.body{padding:12px 24px 8px}
.ftr{padding:12px 24px;flex-direction:column;align-items:flex-start}
.ftr-note{text-align:left}
}
</style>
</head>
<body>
<div class="card">

  <div class="hdr">
    <div class="logo-row">
      <span class="logo">CCM Notes</span>
      <span class="sep-dot">‚Ä¢</span>
      <span class="cat">Neurocritical Care ¬∑ Critical Care</span>
    </div>
    <div class="title">Intracranial Pressure (ICP) Management</div>
    <div class="subtitle">Monroe-Kellie Doctrine ¬∑ CPP Targets ¬∑ Stepwise ICP Protocol ¬∑ Osmotherapy ¬∑ EVD ¬∑ Decompressive Craniectomy</div>
  </div>

  <div class="body">

    <!-- ICP Targets + Monroe-Kellie + CPP -->
    <div class="box">
      <div class="sec-lbl">üìä ICP Targets &amp; Key Principles</div>
      <div class="target-bands">
        <div class="tb-cell tb-normal"><div class="tb-val tb-val-green">&lt;15 mmHg</div><div class="tb-label">Normal ICP</div></div>
        <div class="tb-cell tb-elevated"><div class="tb-val tb-val-amber">15‚Äì20 mmHg</div><div class="tb-label">Borderline ‚Äî monitor closely</div></div>
        <div class="tb-cell tb-critical"><div class="tb-val tb-val-red">&gt;20‚Äì25 mmHg</div><div class="tb-label">Treat ‚Äî ICP Crisis</div></div>
      </div>
      <div class="doctrine-row">
        <div class="doctrine-box">
          <div class="dt-label">Monroe-Kellie Doctrine</div>
          <div style="font-size:11.5px;color:#d0e8e8;line-height:1.45">The cranium is a rigid, fixed-volume box. Volume = Brain (80%) + Blood (10%) + CSF (10%). Increase in any component <strong style="color:#f5a623">must</strong> be compensated by reduction in another ‚Äî once compensatory mechanisms are exhausted, ICP rises exponentially.</div>
        </div>
        <div class="doctrine-box">
          <div class="dt-label">Cerebral Perfusion Pressure (CPP)</div>
          <div class="formula-inline">CPP = MAP ‚àí ICP</div>
          <div style="font-size:11.5px;color:#d0e8e8;line-height:1.45">Target CPP: <span class="val">60‚Äì70 mmHg</span><br>CPP &lt;50 mmHg ‚Üí cerebral ischemia<br>CPP &gt;70 mmHg ‚Üí ARDS risk (vasopressors)<br>Autoregulation intact: CPP 50‚Äì150 mmHg</div>
        </div>
      </div>
    </div>

    <!-- Cushing's Triad -->
    <div class="cushing-alert">
      <div class="cushing-icon">üß†</div>
      <div class="cushing-body">
        <div class="cushing-title">‚ö†Ô∏è Cushing's Triad ‚Äî Herniation Imminent</div>
        <div class="cushing-triad">
          <div class="ct-item">üî¥ Hypertension (widened pulse pressure)</div>
          <div class="ct-item">ü´Ä Bradycardia</div>
          <div class="ct-item">üå¨Ô∏è Irregular / slow respirations</div>
        </div>
        <div class="cushing-action">Cushing's Triad = brainstem compression from tentorial herniation. Emergent intervention required: hyperventilate to PaCO‚ÇÇ 30‚Äì35 mmHg, mannitol/HTS bolus, immediate neurosurgical consult. Pupillary asymmetry/blown pupil = uncal herniation.</div>
      </div>
    </div>

    <!-- Stepwise ICP Protocol -->
    <div class="box green">
      <div class="sec-lbl">üìã Stepwise ICP Management Protocol (Tier 0 ‚Üí 3)</div>
      <div class="step-grid">
        <div class="step-cell tier-1">
          <div class="step-tier">Tier 0 ‚Äî Universal</div>
          <div class="step-title">Head of Bed + Basics</div>
          <div class="step-detail">HOB <span class="val">30¬∞</span>, head midline (no neck flexion)<br>Normothermia (avoid fever ‚Äî 0.5 mmHg ICP rise/¬∞C)<br>Euglycemia <span class="val">140‚Äì180 mg/dL</span><br>Avoid hypoxia (SpO‚ÇÇ &gt;94%) &amp; hypercapnia (PaCO‚ÇÇ 35‚Äì45 mmHg)<br>Adequate analgesia/sedation; avoid Valsalva, coughing<br>Isotonic fluids only</div>
        </div>
        <div class="step-cell tier-2">
          <div class="step-tier">Tier 1 ‚Äî First Line</div>
          <div class="step-title">Osmotherapy</div>
          <div class="step-detail"><strong>Mannitol</strong> 20%: <span class="val">0.5‚Äì1 g/kg IV</span> over 15‚Äì20 min<br><strong>Hypertonic saline</strong> 3%: <span class="val">250 mL IV</span> bolus; or 23.4% via central line<br>CSF drainage via EVD (if placed)<br>Sedation/analgesia optimization: propofol + fentanyl<br>Neuromuscular blockade if refractory agitation</div>
        </div>
        <div class="step-cell tier-3">
          <div class="step-tier">Tier 2 ‚Äî Second Line</div>
          <div class="step-title">Deeper Interventions</div>
          <div class="step-detail">Mild hyperventilation: target PaCO‚ÇÇ <span class="val">30‚Äì35 mmHg</span> (short-term bridge only ‚Äî causes vasoconstriction)<br>High-dose barbiturates: pentobarbital coma (EEG burst suppression)<br>Repeat osmotherapy boluses; serum Na target <span class="val">145‚Äì155 mEq/L</span><br>Optimize CPP with vasopressors (norepinephrine)</div>
        </div>
        <div class="step-cell tier-4">
          <div class="step-tier">Tier 3 ‚Äî Salvage</div>
          <div class="step-title">Surgical Options</div>
          <div class="step-detail"><strong>Decompressive craniectomy</strong>: removes bone flap to allow brain expansion ‚Äî reduces ICP by 50‚Äì60%<br><strong>EVD placement</strong>: continuous or intermittent CSF drainage (target ICP &lt;20)<br>Indications: refractory to medical Rx, GCS deterioration, herniation signs</div>
        </div>
      </div>
    </div>

    <!-- Osmotherapy + Positioning/Temperature -->
    <div class="two-col">
      <div class="box blue" style="border-radius:10px;padding:12px 14px">
        <div class="sec-lbl">üíä Osmotherapy ‚Äî Mannitol vs Hypertonic Saline</div>
        <div class="osmo-grid">
          <div class="osmo-cell oc-mannitol">
            <div class="oc-drug oc-drug-blue">Mannitol 20%</div>
            <div class="item">Dose: <span class="val">0.5‚Äì1 g/kg IV</span> q4‚Äì6h PRN</div>
            <div class="item">Onset: <span class="val">15‚Äì30 min</span>; duration 2‚Äì6h</div>
            <div class="item">Hold if serum osm &gt;<span class="val">320 mOsm/L</span></div>
            <div class="item">Risk: hypotension, hypovolemia, rebound ICP</div>
            <div class="item">Monitor: Osmol gap, BUN/Cr, UO</div>
          </div>
          <div class="osmo-cell oc-hts">
            <div class="oc-drug oc-drug-purple">Hypertonic Saline</div>
            <div class="item">3% NaCl: <span class="val">250 mL IV</span> bolus (peripheral OK)</div>
            <div class="item">23.4% NaCl: <span class="val">30 mL IV</span> via central line only</div>
            <div class="item">Target serum Na: <span class="val">145‚Äì155 mEq/L</span></div>
            <div class="item">Preferred if: hypotension, hypovolemia, renal failure</div>
            <div class="item">Monitor Na q4‚Äì6h; avoid rapid correction</div>
          </div>
        </div>
      </div>
      <div class="box purple" style="border-radius:10px;padding:12px 14px">
        <div class="sec-lbl">üå°Ô∏è Temperature Control &amp; Monitoring</div>
        <div class="item"><strong>Targeted Temperature Management (TTM)</strong>: Normothermia (36‚Äì37¬∞C) is first goal; prevent fever aggressively (each 1¬∞C fever = ‚ÜëICP)</div>
        <div class="item"><strong>Therapeutic hypothermia</strong> (32‚Äì35¬∞C): may reduce ICP in refractory cases; risk of coagulopathy, infection, cardiac arrhythmias</div>
        <div class="item"><strong>ICP monitoring</strong>: Intraventricular catheter (gold standard) ‚Äî allows both monitoring and CSF drainage</div>
        <div class="item">Intraparenchymal probe (Camino, Codman) ‚Äî monitoring only; no drainage</div>
        <div class="item"><strong>DVT prophylaxis</strong>: Delay pharmacologic prophylaxis ‚â•24‚Äì48h post-hemorrhage; use sequential compression devices (SCDs) immediately</div>
        <div class="item">Seizure prophylaxis: levetiracetam or phenytoin for 7 days in traumatic brain injury</div>
      </div>
    </div>

    <!-- Critical Warnings -->
    <div class="box red">
      <div class="sec-lbl">‚ö†Ô∏è Critical Reminders</div>
      <div style="display:grid;grid-template-columns:1fr 1fr;gap:6px">
        <div class="warn-row"><span class="warn-icon">‚óè</span><span class="warn-text"><strong>No hypotonic fluids</strong> (D5W, 0.45% NaCl) ‚Äî lowers serum osmolality, drives water into brain, worsening cerebral edema and ICP</span></div>
        <div class="warn-row"><span class="warn-icon">‚óè</span><span class="warn-text"><strong>Avoid hypoxia</strong> (SpO‚ÇÇ &lt;94%) and <strong>hypercapnia</strong> (PaCO‚ÇÇ &gt;45) ‚Äî both cause cerebral vasodilation and acute ICP spikes</span></div>
        <div class="warn-row"><span class="warn-icon">‚óè</span><span class="warn-text"><strong>Prolonged hyperventilation</strong> (PaCO‚ÇÇ &lt;30 mmHg) causes ischemia via excessive vasoconstriction ‚Äî use as bridge only (&lt;30 min)</span></div>
        <div class="warn-row"><span class="warn-icon">‚óè</span><span class="warn-text"><strong>DVT prophylaxis timing</strong>: Mechanical (SCD) immediately; LMWH/heparin delay ‚â•24‚Äì48h post-haemorrhage; failure to initiate ‚Üí high DVT/PE mortality</span></div>
      </div>
    </div>

  </div>

  <div class="ftr">
    <div class="ftr-left">CCM Notes ¬∑ FOAMed ¬∑ Critical Care Clinical Reference<br><a href="about.html" style="color:#12b5b5;text-decoration:none;font-size:10px;">About</a></div>
    <div class="ftr-note">Based on BTF TBI Guidelines 4th Ed / NCS ICP Guidelines<br>Educational use only</div>
  </div>

</div>
</body>
</html>
